Murtola TJ - Search Results

1

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

Murtola TJ, Tammela TL, Määttänen L, Huhtala H, Platz EA, Ala-Opas M, Stenman UH, Auvinen A. Murtola TJ, et al. Int J Cancer. 2010 Oct 1;127(7):1650-9. doi: 10.1002/ijc.25165. Int J Cancer. 2010. PMID: 20073066

2

Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland.

Nikulainen I, Salminen AP, Seikkula H, Högerman M, Perez IM, Koskinen I, Sairanen J, Nikkola J, Murtola TJ, Vaarala MH, Jousmäki S, Nykopp TK, Isotalo T, Marttila T, Alibeto A, Seppänen M, Palmberg C, Boström PJ. Nikulainen I, et al. Among authors: murtola tj. Acta Oncol. 2023 Aug;62(8):829-835. doi: 10.1080/0284186X.2023.2228446. Epub 2023 Jun 28. Acta Oncol. 2023. PMID: 37377029

3

Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study.

Murtola TJ, Tammela TL, Määttänen L, Hakama M, Auvinen A. Murtola TJ, et al. Eur J Cancer. 2007 Mar;43(4):775-81. doi: 10.1016/j.ejca.2006.12.001. Epub 2007 Jan 23. Eur J Cancer. 2007. PMID: 17251005

4

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A. Murtola TJ, et al. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2226-32. doi: 10.1158/1055-9965.EPI-07-0599. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006910

5

Statins and prostate cancer prevention: where we are now, and future directions.

Murtola TJ, Visakorpi T, Lahtela J, Syvälä H, Tammela TLj. Murtola TJ, et al. Nat Clin Pract Urol. 2008 Jul;5(7):376-87. doi: 10.1038/ncpuro1146. Epub 2008 Jun 10. Nat Clin Pract Urol. 2008. PMID: 18542103 Review.

6

Antidiabetic medication and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A. Murtola TJ, et al. Am J Epidemiol. 2008 Oct 15;168(8):925-31. doi: 10.1093/aje/kwn190. Epub 2008 Aug 11. Am J Epidemiol. 2008. PMID: 18700234

7

Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.

Murtola TJ, Pennanen P, Syvälä H, Bläuer M, Ylikomi T, Tammela TL. Murtola TJ, et al. Prostate. 2009 Jun 15;69(9):1017-23. doi: 10.1002/pros.20951. Prostate. 2009. PMID: 19301305

8

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.

Murtola TJ, Tammela TL, Määttänen L, Ala-Opas M, Stenman UH, Auvinen A. Murtola TJ, et al. Br J Cancer. 2009 Sep 1;101(5):843-8. doi: 10.1038/sj.bjc.6605188. Epub 2009 Aug 4. Br J Cancer. 2009. PMID: 19654575 Free PMC article.

9

False-positive screening results in the Finnish prostate cancer screening trial.

Kilpeläinen TP, Tammela TL, Määttänen L, Kujala P, Stenman UH, Ala-Opas M, Murtola TJ, Auvinen A. Kilpeläinen TP, et al. Among authors: murtola tj. Br J Cancer. 2010 Feb 2;102(3):469-74. doi: 10.1038/sj.bjc.6605512. Epub 2010 Jan 5. Br J Cancer. 2010. PMID: 20051951 Free PMC article. Clinical Trial.

10

Statin use is associated with improved prostate cancer survival: is it time for a clinical trial?

Murtola TJ. Murtola TJ. Expert Rev Anticancer Ther. 2010 Oct;10(10):1563-7. doi: 10.1586/era.10.137. Expert Rev Anticancer Ther. 2010. PMID: 20942627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters